Skip to main content
. 2020 Oct 1;63(1):e86. doi: 10.1192/j.eurpsy.2020.84

Table 1.

Demography, diagnosing physician, and prescriber of ADHD-specific medication.

Age and sex a ADHD total Initial ADHD medication No initial ADHD medication
Total, n (%) 2,380 (100%) 624 (26%) 1,756 (74%)
Female, n (%) 961 (100%) 267 (28%) 694 (72%)
Male, n (%) 1,419 (100%) 357 (25%) 1,062 (75%)
Age (years) mean ± SD 34.6 ± 9.9 34.9 ± 9.3 34.6 ± 10.2
Age difference initial ADHD medication vs. no medication p = 0.42
Sex difference initial ADHD medication vs. no medication p = 0.17
Diagnosing physician (speciality of office-based outpatient) and inpatient diagnosis of initial aADHD diagnosis at index quarter (no significance tested)
General practitioner 980 of 2,380 (41%) 173 of 624 (28%) 807 of 1,756 (46%)
Psych MD 778 of 2,380 (33%) 352 of 624 (56%) 426 of 1,756 (24%)
Psych 95 of 2,380 (4%) 17 of 624 (3%) 78 of 1,756 (4%)
Inpatient diagnosis 557 of 2,380 (23%) 178 of 624 (29%) 379 of 1,756 (22%)
Number of individuals with at least one prescription of ADHD-specific medication in the first year of follow-up
At least one prescription of ADHD-specific medication 759 of 2,380 (32%) 624 of 624 (100%)
Prescribing physician of ADHD-specific medication (outpatient) for those with at least one prescription of ADHD-specific medication in the first year of follow-up
General practitioner 123 of 759 (16%) 78 of 624 (13%)
Psych MD 526 of 759 (69%) 398 of 624 (64%)

One individual may have multiple ADHD diagnoses and prescriptions from multiple physicians.

Abbreviation: ADHD, attention-deficit/hyperactivity disorder.

a

Tested outcomes: age and sex differences between individuals with initial ADHD-medication and no initial ADHD-medication. No statistical difference between individuals with initial ADHD-medication and without concerning sex (Chi-square test; p = 0.17) and age (t test; p = 0.42) at index.